65638-82-6

Basic information

• Product Name: L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosyl]-, methyl ester
• CAS NO: 65638-82-6
• Molecular Formula: C28H38N2O6
• Molecular Weight: 498.62
• Mol File: 65638-82-6.mol

Chemical Properties

• CAS DataBase Reference: L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosyl]-, methyl ester(65638-82-6)
• EPA Substance Registry System: L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosyl]-, methyl ester(65638-82-6)

Safety Data

• Hazardous Substances Data: 65638-82-6(Hazardous Substances Data)

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 642073-55-0 N-Boc-3-iodo-Tyr(Bzl)-Leu-OMe 
• 911675-14-4 Z-(7-bromo)Trp-OEt 
• 911675-15-5 Z-(7-bromo)Trp-NHMe 
• 2130-96-3 O-benzyl-N-tert-butoxycarbonyl-L-tyrosine 
• 7517-19-3 methyl (L)-leucinate hydrochloride 
• 27601-29-2 t-butyloxycarbonyl-O-benzyl-L-tyrosine hydroxysuccinimide ester 
• 2666-93-5 (S)-Leu-OMe 

Downstream Products

• 467222-63-5 N-Boc-Tyr(Bn)-Leu-OH 
• 1220669-64-6 octanoyl-Tyr(Bzl)-Leu-OMe 
• 642073-55-0 N-Boc-3-iodo-Tyr(Bzl)-Leu-OMe 
• 642073-58-3 N-Boc-3-iodo-Tyr(Bn)-Leu-7-bromo-Trp-OMe 
• 700376-96-1 N-Boc-3-iodo-Tyr(Bn)-Leu-OH 
• 911675-56-4 N-Boc-Tyr(Bn)-Leu-Trp-NH(CH₂)4NHBoc 

Relevant articles and documents

Environmentally benign peptide synthesis using liquid-assisted ball-milling: Application to the synthesis of Leu-enkephalin

This paper describes an original methodology for peptide bond synthesis avoiding toxic solvents and reactants. Ball-milling stoichiometric amounts of Boc-protected α-amino acid N-carboxyanhydrides (Boc-AA-NCA) or Boc-protected α-amino acid N-hydroxysuccin

NOVEL SMALL MOLECULE DNAK INHIBITORS

Methods of inhibiting HSP70 proteins, agents causing the inhibition of HSP70 proteins, and the effects of such inhibition on cell proliferation. Anti-microbial agents comprising small molecules, or pharmaceutical salts thereof, disclosed herein and furthe

Linear TMC-95-based proteasome inhibitors

We have designed and evaluated 45 linear analogues of the natural constrained cyclopeptide TMC-95A. These synthetically less demanding molecules are based on the tripeptide sequence Y-N-W of TMC-95A. Structural variations in the amino acid side chains and

Synthesis of Macrocyclic Peptide Analogues of Proteasome Inhibitor TMC-95A

The synthesis of three constrained macrocyclic peptide analogues 1 of TMC-95A as potential proteasome inhibitors is described. The key step involves a Ni(O)-mediated macrocyclization of tripeptides 2 bearing halogenated aromatic side chains for the formation of the biaryl junction. In addition, an enantioselective preparation of L-7-bromotryptophan methyl ester 3 using a Corey-O'Donnell alkylation of the glycine benzophenone imine was achieved in good overall yield with very high ee (>85%) on a multigram scale.